[Pharmacologic treatment of mild proliferation of prostatic cancer].
In the paper, pathophysiological and clinical foundations of modern conservative therapy of mild proliferation of prostatic cancer are discussed in a short outline. The problems of treatment with hormonal and non-hormonal preparations are presented against the background of the mechanism of action of pharmacological preparations. The drugs, their dosage, effectiveness and also side effects are discussed. The importance is stressed of the drugs blocking the alpha-1 adrenergic receptors in the treatment of mild proliferation of prostatic cancer with additional beneficial mechanisms of action for the organism.
Dutkiewicz
S
S
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002455:Cell Division / Q000187:drug effects; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000473:pathology
D000317:Adrenergic alpha-Antagonists; D000924:Anticholesteremic Agents; D018931:Antineoplastic Agents, Hormonal
Leczenie farmakologiczne łagodnego rozrostu gruczołu krokowego.